Antimicrobial Agents and Chemotherapy · 2001 · 112 citations · 32 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial GeneticsAntibiotic ResistanceAntibiotic Resistance MechanismsBeta-lactam ResistanceEfflux-mediated ResistancePlasmid GeneticsResistance GenesBeta-lactamase EvolutionBeta-lactamase GenesBeta-lactamase Inhibitor ResistanceBeta-lactamase InhibitorsClass D OxacillinasesOxacillin ResistancePseudomonas Aeruginosa ResistanceResistance Gene-mediated Resistance
Pseudomonas aeruginosa clinical isolate SOF-1 was resistant to cefepime and susceptible to ceftazidime. This resistance phenotype was explained by the expression of OXA-31, which shared 98% amino acid identity with a class D beta-lactamase, OXA-1. The oxa-31 gene was located on a ca. 300-kb nonconjugative plasmid and on a class 1 integron. No additional efflux mechanism for cefepime was detected in P. aeruginosa SOF-1. Resistance to cefepime and susceptibility to ceftazidime in P. aeruginosa were conferred by OXA-1 as well.
32
pBBR1MCS: a broad-host-range cloning vector.
Michael E. Kovach, Robert W. Phillips, Philip H. Elzer et al. · PubMed · 1994 · 899 citations
Laurent Poirel, Thierry Naas, Delphine Nicolas et al. · Antimicrobial Agents and Chemotherapy · 2000 · 558 citations · Full text